5: Opioid Risk Assessment, Mitigation, and Management
This activity focuses on the assessment, mitigation and management of risk when prescribing opioids for analgesia. Learners are introduced to the concept of universal precautions and their role in opioid therapy, as well as to practical monitoring and documentation strategies. The fundamental principles of urine drug testing and interpretation are also reviewed, as is the differential diagnosis of opioid misuse. Special attention is given to overdose prevention, naloxone co-prescribing, and how to recognize and respond to an emerging opioid use disorder when prescribing chronic opioid therapy for pain.
Integrating Care: The Role of MOUD in Addressing Opioid Use Disorder and Infectious Disease
Due to the opioid epidemic, over 2.5 million adults in the U.S. have opioid use disorder (OUD), yet only 25% of those who need treatment receive recommended medication for opioid use disorder (MOUD). Alongside the rising rates of OUD, there has been an increase in infectious diseases such as HIV, hepatitis B and C, endocarditis and skin and soft-tissue infections, particularly among people who inject drugs. These intertwining epidemics have not been sufficiently addressed, but MOUD — combined with appropriate substance use treatment supports and health care services — represents an opportunity to reduce risk and improve health outcomes.
Understanding Substance Use Disorders
Provides a basic introduction of the concepts of the disease of addiction and the role of the reward system. Using neuroscience concepts as a foundation, clinical manifestations of the disease of addiction are then discussed in the form of case-based presentations.
Alcohol and Drug Use Disorder
Outlines the basic concepts of alcohol and drug use disorders. Standard drink sizes, screening for alcohol use disorders and an introduction to alcohol withdrawal management are discussed. A basic overview of the major drug use disorders are then discussed in a clinically-relevant manner.
The History and Defining Features of the Current Opioid Epidemic
Provides an overview of the history of opioid use with an overview of contributing factors to the current epidemic. Using clinical cases, opioid use disorder is then discussed in detail. Finally, there is a discussion of treatment options.
Medication and Behavioral Treatment of Substance Use Disorders
Introduces evidence-based clinical practices of pharmacotherapy and behavioral treatments for substance use disorders. Off label medications and psychosocial support programs are also discussed.
What Now: Relevance of Xylazine in the Age of Opioid Use Disorder – Guidance for OUD Treatment Providers
As the opioid use crisis continues to progress, communities across the country are now being faced with additional dangers such as the misuse of Xylazine, a powerful sedative commonly used for animals in the drug supply. Recent studies indicate these potent substances when used with opioids increase overdose risk and complicates treatment and long-term healthcare. Join us today as we discuss the history and context of Xylazine and opioid use as well as options for treatment and care.
Screening, Brief Intervention, Referral to Treatment (SBIRT) for Substance Use Disorders in Primary Care Settings
Given the high prevalence of substance use disorders among primary care patients, as well as the continuing epidemic of opioid use disorders, it is important to routinely screen your patients for substance use disorders. This module describes the SBIRT model (Screening, Brief Intervention, Referral to Treatment), an evidence-based practice that has shown significant success in varied clinic settings at reducing alcohol and illicit substance use. Validated, structured screening tools are provided and the components of how to implement brief interventions with your patients are described. The module also discusses approved treatments for substance use disorders, as well as guidelines for when to refer your patient for other options.
Screening for Substance Use in Primary Care: Screening Tools and Guidance for Implementation
Substance use drives poor health outcomes in the general population. SUD continues to lead to more death and disability than any other preventable condition, with alcohol being the third leading cause of preventable death in the United States. Drug-related overdoses also continue to climb with > 108,000 overdose deaths per year as well as the leading all-cause mortality under the age of 50. Primary care is generally not thought of as a place to access mental health care, but it may be a critical tool in noticing substance use behaviors and proactively loop patients into needed care. This webinar aims to introduce screening tools that can be administered during primary care visits.
3: Screening, Assessment and Treatment Initiation for SUD
Risky substance use and substance use disorders may often go unrecognized in primary care settings, either due to insufficient screening or provider discomfort with how to manage a positive screening. There are several brief, simple, validated screening tools that can provide information to indicate risky substance use or the possible presence of a substance use disorder. This information can inform providers as to whether a simple brief intervention or a referral to treatment is warranted. This module will: introduce screening tools related to drug and alcohol use; review more detailed substance use, medical, and psychiatric assessment considerations; demonstrate effective strategies for brief interventions; and discuss considerations for treatment referrals.
